Five-year, Pharmacovigilance

Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

NTC Srl United Kingdom United States of America France Germany Spain Italy Austria

View original content:https://www.prnewswire.co.uk/news-releases/five-year-pharmacovigilance-study-by-ntc-confirms-safety-of-fixed-dose-eye-drops-for-post-cataract-surgery-302505372.html

en | boerse | 67989152 |